Through the 90-day period concluding January 10, 2026, Olema Pharmaceuticals's top three insider stakeholders include TenPercentOwner Capital Life Sciences Investors, Llc Bain (4.30Mn shares), Director Cyrus Harmon (858.29K shares), TenPercentOwner Biocapital Advisors Lp Paradigm (783.12K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Capital Life Sciences Investors, Llc Bain | 4,300,000 | 13 Jan, 2025 | |
| Cyrus Harmon | 858,287 | 29 Dec, 2025 | |
| Biocapital Advisors Lp Paradigm | 783,118 | 05 Aug, 2024 | |
| G. Walmsley Graham | 700,761 | 18 Dec, 2024 | |
| David C. Myles | Ch. Discov. & Non Clin Dev Off | 542,881 | 23 Dec, 2025 |
| Partners L P/Il Bvf | 447,526 | 14 Jan, 2025 | |
| Andrew Rappaport | 385,965 | 25 Nov, 2025 | |
| Shane William Charles Kovacs | Ch. Operating & Financial Off. | 243,549 | 09 Dec, 2025 |
| Sean Bohen | President And Ceo | 237,650 | 30 Dec, 2025 |
| Naseem Zojwalla | Chief Medical Officer | 4,488 | 23 Dec, 2025 |
| Kinney Horn | Chief Business Officer | 2,458 | 14 Mar, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 26 Dec, 2025 | Sean Bohen | Common Stock | D | 8,500 | $0.00 | 237,650 | D | G |
| 23 Dec, 2025 | Naseem Zojwalla | Common Stock | D | 99,509 | $27.66 | 4,488 | D | S |
| 23 Dec, 2025 | Naseem Zojwalla | Common Stock | A | 50,000 | $7.02 | 103,997 | D | M |
| 22 Dec, 2025 | Cyrus Harmon | Common Stock | D | 2,881 | $28.53 | 741,259 | D | S |
| 22 Dec, 2025 | Naseem Zojwalla | Common Stock | A | 42,818 | $15.25 | 146,815 | D | M |
| 22 Dec, 2025 | Naseem Zojwalla | Common Stock | D | 100,000 | $28.04 | 53,997 | D | S |
| 22 Dec, 2025 | Naseem Zojwalla | Common Stock | A | 7,182 | $7.02 | 153,997 | D | M |
| 19 Dec, 2025 | Ian T Clark | Common Stock | A | 21,520 | $3.61 | 231,210 | D | M |
| 19 Dec, 2025 | Ian T Clark | Common Stock | A | 21,520 | $7.84 | 252,730 | D | M |
| 19 Dec, 2025 | Ian T Clark | Common Stock | D | 29,904 | $28.83 | 234,896 | D | S |
| 19 Dec, 2025 | Ian T Clark | Common Stock | D | 193,056 | $29.71 | 41,840 | D | S |
| 19 Dec, 2025 | Ian T Clark | Common Stock | A | 12,070 | $4.08 | 264,800 | D | M |
| 19 Dec, 2025 | Ian T Clark | Common Stock | D | 41,840 | $30.48 | 0 | D | S |
| 19 Dec, 2025 | Ian T Clark | Common Stock | A | 209,690 | $4.41 | 209,690 | D | M |
| 19 Dec, 2025 | David C. Myles | Common Stock | D | 1,225 | $28.08 | 601,656 | D | S |
| 19 Dec, 2025 | David C. Myles | Common Stock | D | 9,000 | $0.00 | 542,881 | D | G |
| 19 Dec, 2025 | David C. Myles | Common Stock | D | 43,729 | $30.40 | 557,927 | D | S |
| 19 Dec, 2025 | David C. Myles | Common Stock | D | 6,046 | $31.39 | 551,881 | D | S |
| 19 Dec, 2025 | Naseem Zojwalla | Common Stock | A | 40,000 | $15.25 | 173,997 | D | M |
| 19 Dec, 2025 | Naseem Zojwalla | Common Stock | D | 12,921 | $28.93 | 103,997 | D | S |